TAS-108 citrate
Product Specifications
CAS Number
229634-98-4
Target
Others
Related Pathways
Others
Bioactivity
TAS-108, also known as SR16234, is a synthetic, antiestrogenic steroidal compound with potential antitumor activity. TAS-108 binds to and inhibits estrogenic receptor alpha (ERa), mainly expressed in the mammary gland and uterus and upregulated in estrogen-dependent tumors. Blockage of ERa by TAS-108 prevents the binding and effects of estrogen and may lead to an inhibition of estrogen-dependent cancer cell proliferation. TAS-108 also is a partial agonist of the estrogenic receptor beta (ERb), expressed in many tissues including the central nervous system, urogenital tract, bone and cardiovascular system, thereby exerting a positive effect on these tissues.
Smiles
C(CC(O)=O)(CC(O)=O)(C(O)=O)O.C[C@H]1[C@]2([C@]3([C@@](C)([C@@H](CCOC4=C(OC)C=C(CN(CC)CC)C=C4)CC3)CC[C@@]2(C=5C(C1)=CC(O)=CC5)[H])[H])[H]
Molecular Formula
C39H55NO10
Molecular Weight
697.86
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6247207-01 0.1 mL
ATM, phosphorylated (Ser1981) (Ataxia Telangiectasia Mutated, ATA, AT Complementation Group A, ATC, ATD, ATE) (MaxLight 750)
Sign In for Pricing
View Details MBS6247207-02 5x 0.1 mL
ATM, phosphorylated (Ser1981) (Ataxia Telangiectasia Mutated, ATA, AT Complementation Group A, ATC, ATD, ATE) (MaxLight 750)
Sign In for Pricing
View Details